Abstract
The WHO has declared that obesity is one of the top five risk conditions in the world. Body adiposity occurs as a consequence of an imbalance between food intake and energy expenditure. The hypothalamus integrates complex neural and humoral signals that coordinate the initiation and termination of feeding and regulates energy expenditure. In the last decade there has been considerable interest in the role of gut hormones in governing hunger and satiety signals in the brain. Ghrelin, a small peptide synthesized in the stomach, stimulates food intake while peptide YY (PYY), oxyntomodulin (OXM), glucagon like peptide-1 (GLP-1), cholecystokinin (CCK) and pancreatic polypeptide (PP) inhibit appetite To date, pharmacological approaches used to alter gut hormones administration may provide physiological and therapeutic solutions for appetite control and long-term anti-obesity therapy. Here we review the recent advances in this field.
Keywords: Gut peptides, PYY, Oxyntomodulin, GLP-1, Ghrelin, obesity
Current Nutrition & Food Science
Title: Adiposity and the Gut - The Role of Gut Hormones
Volume: 3 Issue: 1
Author(s): Vian Amber and Stephen R. Bloom
Affiliation:
Keywords: Gut peptides, PYY, Oxyntomodulin, GLP-1, Ghrelin, obesity
Abstract: The WHO has declared that obesity is one of the top five risk conditions in the world. Body adiposity occurs as a consequence of an imbalance between food intake and energy expenditure. The hypothalamus integrates complex neural and humoral signals that coordinate the initiation and termination of feeding and regulates energy expenditure. In the last decade there has been considerable interest in the role of gut hormones in governing hunger and satiety signals in the brain. Ghrelin, a small peptide synthesized in the stomach, stimulates food intake while peptide YY (PYY), oxyntomodulin (OXM), glucagon like peptide-1 (GLP-1), cholecystokinin (CCK) and pancreatic polypeptide (PP) inhibit appetite To date, pharmacological approaches used to alter gut hormones administration may provide physiological and therapeutic solutions for appetite control and long-term anti-obesity therapy. Here we review the recent advances in this field.
Export Options
About this article
Cite this article as:
Amber Vian and Bloom R. Stephen, Adiposity and the Gut - The Role of Gut Hormones, Current Nutrition & Food Science 2007; 3 (1) . https://dx.doi.org/10.2174/1573401310703010075
DOI https://dx.doi.org/10.2174/1573401310703010075 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications
Current Drug Targets The Importance of Lost Minerals in Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Hypoglycemia Induces Tau Hyperphosphorylation
Current Alzheimer Research The Follow-Up of Dietary Treatment of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Patent Selections
Recent Patents on Biomarkers Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Author Index To Volume 2
Current Hypertension Reviews Kinases as Targets for ENaC Regulation
Current Molecular Pharmacology Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology Atherosclerotic Process in Seroreverter Children and Adolescents Exposed to Fetal Antiretroviral Therapy
Current HIV Research Cu(II) Schiff Base as Catalyst in the Synthesis of 1,8-Dioxodecahydroacridine
Combinatorial Chemistry & High Throughput Screening Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?
Current Pharmaceutical Design Synthesis and Endothelin Receptor Binding Affinity of a Novel Class of 2-Substituted-4-aryl-3-quinolinecarboxylic Acid Derivatives
Medicinal Chemistry Schistosoma mansoni Changes the Activity of Phase II Drug-Metabolizing Enzymes: Role of Praziquantel as Antibilharzial Drug
Drug Metabolism Letters Endothelin-1-Induced Signaling Pathways in Vascular Smooth Muscle Cells
Current Vascular Pharmacology Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets New Perspectives in the Pharmacological Potential of Naringin in Medicine
Current Medicinal Chemistry